NCT06184971

Brief Summary

This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investigators aim to evaluate which specific factors contribute to improved patient outcomes, to help guide potential improvements in patient care and resource utilization.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started May 2024

Typical duration for all trials

Geographic Reach
1 country

14 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
May 2024Dec 2026

First Submitted

Initial submission to the registry

December 13, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 29, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

May 6, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

December 13, 2023

Last Update Submit

March 27, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Death

    Patient death

    10 years

  • Kasai procedure

    Need for biliary diversion procedure, including the Kasai portoenterostomy

    10 years

  • Liver transplant

    Need for liver transplant

    10 years

Secondary Outcomes (6)

  • Clearance of jaundice

    6 months

  • Bilirubin level

    10 years

  • Cholangitis

    10 years

  • Bleeding

    10 years

  • Presentation to ED

    10 years

  • +1 more secondary outcomes

Eligibility Criteria

AgeUp to 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children 12 years and younger (at the time of the qualifying encounter for care) who were diagnosed with biliary atresia, underwent surgical intervention for biliary atresia, and/or had an encounter for care related to biliary atresia at a participating institution during the study period. Patients who did not undergo surgery will be included (e.g. patients who died before surgery).

You may qualify if:

  • Children with a healthcare encounter related to biliary atresia at a participating institution during the study period (January 1st, 2012 through December 31st, 2021)
  • Age 12 years and younger at the time of the qualifying encounter during the study period (encompassing patients born between January 2nd, 1999 through December 31st, 2021)
  • Diagnosis of biliary atresia, based on one of the following ICD-10 codes:
  • Q44.2 Atresia of bile ducts
  • Q44.3 Congenital stenosis and stricture of bile ducts
  • Q44.4 Disorders of the biliary tract with major complication or comorbidity
  • Q44.5 Other congenital malformations of the bile ducts
  • Q44.6 Disorders of the biliary tract without major complication or comorbidity

You may not qualify if:

  • Patients aged 13 years old or older during the study period (i.e. those born before January 2nd, 1999)
  • Patients born and/or diagnosed with biliary atresia after the end of the study period (i.e. those born after December 31st, 2021)
  • No diagnosis of biliary atresia
  • History of biliary atresia without any episodes of care related to biliary atresia during the study period (e.g. a teenager with history of BA who underwent Kasai procedure as an infant and has no current issues related to their BA and is receiving care for an unrelated reason)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Connecticut Children's Medical Center

Hartford, Connecticut, 06106, United States

Location

Yale University

New Haven, Connecticut, 06510, United States

Location

Eastern Maine Medical Center

Bangor, Maine, 04401, United States

Location

Maine Medical Center

Portland, Maine, 04102, United States

Location

Massachusetts General Hospital for Children

Boston, Massachusetts, 02114, United States

Location

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

Location

Baystate

Springfield, Massachusetts, 01199, United States

Location

UMass Memorial Medical Center

Worcester, Massachusetts, 01605, United States

Location

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

Albany Medical Center/Bernard & Millie Duke's Children's Hospital

Albany, New York, 12208, United States

Location

John R. Oishei Children's Hospital

Buffalo, New York, 14203, United States

Location

University of Rochester Medical Center/Golisano Children's Hospital

Rochester, New York, 14642, United States

Location

SUNY Upstate Medical University

Syracuse, New York, 13210, United States

Location

Rhode Island Hospital/Hasbro Children's Hospital

Providence, Rhode Island, 02905, United States

Location

MeSH Terms

Conditions

Biliary Atresia

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesDigestive System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Robert Cowles, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2023

First Posted

December 29, 2023

Study Start

May 6, 2024

Primary Completion

May 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations